A multicenter,double-blind,randomized placebo-controlled phase Ⅱ/Ⅲ clinical trial of meplazumab in the treatment of COVID-19
WEI Ding
ZHANG Zheng
ZHENG Zhaohui
ZHANG Kui
LU Hongzhou
LIU Yingxia
SHEN Yinzhong
WANG Li
ZHANG Shuai
YANG Xiangmin
SHI Hongwei
LIU Shuangshuang
TANG Hao
CHEN Xiaochun
ZHU Ping
BIAN Huijie
CHEN Zhinan
Keywords：CD147meplazumabCOVID-19clinical trial
Publication Date：2023-07-28
Online Publishing Date：2026-08-26(First online date of this platform, not the publication date of the document)
Pages：7( 589-594,601 )